Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease.
LPI (LP Information)' newest research report, the "Inflammatory Bowel Disease Drugs Industry Forecast" looks at past sales and reviews total world Inflammatory Bowel Disease Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Inflammatory Bowel Disease Drugs sales for 2023 through 2029. With Inflammatory Bowel Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inflammatory Bowel Disease Drugs industry.
This Insight Report provides a comprehensive analysis of the global Inflammatory Bowel Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inflammatory Bowel Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inflammatory Bowel Disease Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inflammatory Bowel Disease Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inflammatory Bowel Disease Drugs.
The global Inflammatory Bowel Disease Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressful lifestyle propels the growth of the market. The increase in healthcare expenditure by government and private organizations is anticipated to increase the market growth.
This report presents a comprehensive overview, market shares, and growth opportunities of Inflammatory Bowel Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Amino-salicylates
- Antibiotics
- Corticosteroids
- Immunomodulators
- Biologics
- Others
Segmentation by application
- Ulcerative Colitis
- Crohns Disease
- Indeterminate Colitis
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Abbott Laboratories
- Biocon Ltd
- Roche
- Johnson and Johnson
- Mylan Pharmaceuticals
- Novartis AG
- Pfizer
- Quest Medical
- Sanofi
- Takeda Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Inflammatory Bowel Disease Drugs market?
What factors are driving Inflammatory Bowel Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inflammatory Bowel Disease Drugs market opportunities vary by end market size?
How does Inflammatory Bowel Disease Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global Inflammatory Bowel Disease Drugs Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inflammatory Bowel Disease Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Inflammatory Bowel Disease Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Inflammatory Bowel Disease Drugs by Country/Region, 2018, 2022 & 2029
2.2 Inflammatory Bowel Disease Drugs Segment by Type
2.2.1 Amino-salicylates
2.2.2 Antibiotics
2.2.3 Corticosteroids
2.2.4 Immunomodulators
2.2.5 Biologics
2.2.6 Others
2.3 Inflammatory Bowel Disease Drugs Sales by Type
2.3.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Inflammatory Bowel Disease Drugs Sale Price by Type (2018-2023)
2.4 Inflammatory Bowel Disease Drugs Segment by Application
2.4.1 Ulcerative Colitis
2.4.2 Crohns Disease
2.4.3 Indeterminate Colitis
2.4.4 Others
2.5 Inflammatory Bowel Disease Drugs Sales by Application
2.5.1 Global Inflammatory Bowel Disease Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Inflammatory Bowel Disease Drugs Sale Price by Application (2018-2023)
3 Global Inflammatory Bowel Disease Drugs by Company
3.1 Global Inflammatory Bowel Disease Drugs Breakdown Data by Company
3.1.1 Global Inflammatory Bowel Disease Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Inflammatory Bowel Disease Drugs Sales Market Share by Company (2018-2023)
3.2 Global Inflammatory Bowel Disease Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Inflammatory Bowel Disease Drugs Revenue by Company (2018-2023)
3.2.2 Global Inflammatory Bowel Disease Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Inflammatory Bowel Disease Drugs Sale Price by Company
3.4 Key Manufacturers Inflammatory Bowel Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inflammatory Bowel Disease Drugs Product Location Distribution
3.4.2 Players Inflammatory Bowel Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Inflammatory Bowel Disease Drugs by Geographic Region
4.1 World Historic Inflammatory Bowel Disease Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Inflammatory Bowel Disease Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Inflammatory Bowel Disease Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Inflammatory Bowel Disease Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Inflammatory Bowel Disease Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Inflammatory Bowel Disease Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Inflammatory Bowel Disease Drugs Sales Growth
4.4 APAC Inflammatory Bowel Disease Drugs Sales Growth
4.5 Europe Inflammatory Bowel Disease Drugs Sales Growth
4.6 Middle East & Africa Inflammatory Bowel Disease Drugs Sales Growth
5 Americas
5.1 Americas Inflammatory Bowel Disease Drugs Sales by Country
5.1.1 Americas Inflammatory Bowel Disease Drugs Sales by Country (2018-2023)
5.1.2 Americas Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023)
5.2 Americas Inflammatory Bowel Disease Drugs Sales by Type
5.3 Americas Inflammatory Bowel Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inflammatory Bowel Disease Drugs Sales by Region
6.1.1 APAC Inflammatory Bowel Disease Drugs Sales by Region (2018-2023)
6.1.2 APAC Inflammatory Bowel Disease Drugs Revenue by Region (2018-2023)
6.2 APAC Inflammatory Bowel Disease Drugs Sales by Type
6.3 APAC Inflammatory Bowel Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Inflammatory Bowel Disease Drugs by Country
7.1.1 Europe Inflammatory Bowel Disease Drugs Sales by Country (2018-2023)
7.1.2 Europe Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023)
7.2 Europe Inflammatory Bowel Disease Drugs Sales by Type
7.3 Europe Inflammatory Bowel Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inflammatory Bowel Disease Drugs by Country
8.1.1 Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Type
8.3 Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs
10.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
10.4 Industry Chain Structure of Inflammatory Bowel Disease Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inflammatory Bowel Disease Drugs Distributors
11.3 Inflammatory Bowel Disease Drugs Customer
12 World Forecast Review for Inflammatory Bowel Disease Drugs by Geographic Region
12.1 Global Inflammatory Bowel Disease Drugs Market Size Forecast by Region
12.1.1 Global Inflammatory Bowel Disease Drugs Forecast by Region (2024-2029)
12.1.2 Global Inflammatory Bowel Disease Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inflammatory Bowel Disease Drugs Forecast by Type
12.7 Global Inflammatory Bowel Disease Drugs Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Biocon Ltd
13.2.1 Biocon Ltd Company Information
13.2.2 Biocon Ltd Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biocon Ltd Main Business Overview
13.2.5 Biocon Ltd Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.3.3 Roche Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Johnson and Johnson
13.4.1 Johnson and Johnson Company Information
13.4.2 Johnson and Johnson Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson and Johnson Main Business Overview
13.4.5 Johnson and Johnson Latest Developments
13.5 Mylan Pharmaceuticals
13.5.1 Mylan Pharmaceuticals Company Information
13.5.2 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.5.3 Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Pharmaceuticals Main Business Overview
13.5.5 Mylan Pharmaceuticals Latest Developments
13.6 Novartis AG
13.6.1 Novartis AG Company Information
13.6.2 Novartis AG Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis AG Main Business Overview
13.6.5 Novartis AG Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.7.3 Pfizer Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Quest Medical
13.8.1 Quest Medical Company Information
13.8.2 Quest Medical Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.8.3 Quest Medical Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Quest Medical Main Business Overview
13.8.5 Quest Medical Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.9.3 Sanofi Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Takeda Pharmaceutical
13.10.1 Takeda Pharmaceutical Company Information
13.10.2 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
13.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Takeda Pharmaceutical Main Business Overview
13.10.5 Takeda Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Inflammatory Bowel Disease Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Inflammatory Bowel Disease Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Amino-salicylates
Table 4. Major Players of Antibiotics
Table 5. Major Players of Corticosteroids
Table 6. Major Players of Immunomodulators
Table 7. Major Players of Biologics
Table 8. Major Players of Others
Table 9. Global Inflammatory Bowel Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 10. Global Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
Table 11. Global Inflammatory Bowel Disease Drugs Revenue by Type (2018-2023) & ($ million)
Table 12. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2018-2023)
Table 13. Global Inflammatory Bowel Disease Drugs Sale Price by Type (2018-2023) & (USD/Unit)
Table 14. Global Inflammatory Bowel Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 15. Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2018-2023)
Table 16. Global Inflammatory Bowel Disease Drugs Revenue by Application (2018-2023)
Table 17. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application (2018-2023)
Table 18. Global Inflammatory Bowel Disease Drugs Sale Price by Application (2018-2023) & (USD/Unit)
Table 19. Global Inflammatory Bowel Disease Drugs Sales by Company (2018-2023) & (K Units)
Table 20. Global Inflammatory Bowel Disease Drugs Sales Market Share by Company (2018-2023)
Table 21. Global Inflammatory Bowel Disease Drugs Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Company (2018-2023)
Table 23. Global Inflammatory Bowel Disease Drugs Sale Price by Company (2018-2023) & (USD/Unit)
Table 24. Key Manufacturers Inflammatory Bowel Disease Drugs Producing Area Distribution and Sales Area
Table 25. Players Inflammatory Bowel Disease Drugs Products Offered
Table 26. Inflammatory Bowel Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Inflammatory Bowel Disease Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Inflammatory Bowel Disease Drugs Sales Market Share Geographic Region (2018-2023)
Table 31. Global Inflammatory Bowel Disease Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Inflammatory Bowel Disease Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Inflammatory Bowel Disease Drugs Sales Market Share by Country/Region (2018-2023)
Table 35. Global Inflammatory Bowel Disease Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Inflammatory Bowel Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 38. Americas Inflammatory Bowel Disease Drugs Sales Market Share by Country (2018-2023)
Table 39. Americas Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2018-2023)
Table 41. Americas Inflammatory Bowel Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 42. Americas Inflammatory Bowel Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 43. APAC Inflammatory Bowel Disease Drugs Sales by Region (2018-2023) & (K Units)
Table 44. APAC Inflammatory Bowel Disease Drugs Sales Market Share by Region (2018-2023)
Table 45. APAC Inflammatory Bowel Disease Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Inflammatory Bowel Disease Drugs Revenue Market Share by Region (2018-2023)
Table 47. APAC Inflammatory Bowel Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 48. APAC Inflammatory Bowel Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 49. Europe Inflammatory Bowel Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 50. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Country (2018-2023)
Table 51. Europe Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2018-2023)
Table 53. Europe Inflammatory Bowel Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 54. Europe Inflammatory Bowel Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Inflammatory Bowel Disease Drugs Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Inflammatory Bowel Disease Drugs
Table 62. Key Market Challenges & Risks of Inflammatory Bowel Disease Drugs
Table 63. Key Industry Trends of Inflammatory Bowel Disease Drugs
Table 64. Inflammatory Bowel Disease Drugs Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Inflammatory Bowel Disease Drugs Distributors List
Table 67. Inflammatory Bowel Disease Drugs Customer List
Table 68. Global Inflammatory Bowel Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Inflammatory Bowel Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Inflammatory Bowel Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Inflammatory Bowel Disease Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Inflammatory Bowel Disease Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Inflammatory Bowel Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Inflammatory Bowel Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Inflammatory Bowel Disease Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Abbott Laboratories Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Abbott Laboratories Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 84. Abbott Laboratories Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 85. Abbott Laboratories Main Business
Table 86. Abbott Laboratories Latest Developments
Table 87. Biocon Ltd Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Biocon Ltd Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 89. Biocon Ltd Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 90. Biocon Ltd Main Business
Table 91. Biocon Ltd Latest Developments
Table 92. Roche Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 94. Roche Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Johnson and Johnson Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson and Johnson Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 99. Johnson and Johnson Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 100. Johnson and Johnson Main Business
Table 101. Johnson and Johnson Latest Developments
Table 102. Mylan Pharmaceuticals Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 104. Mylan Pharmaceuticals Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 105. Mylan Pharmaceuticals Main Business
Table 106. Mylan Pharmaceuticals Latest Developments
Table 107. Novartis AG Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis AG Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 109. Novartis AG Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 110. Novartis AG Main Business
Table 111. Novartis AG Latest Developments
Table 112. Pfizer Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 114. Pfizer Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Quest Medical Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Quest Medical Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 119. Quest Medical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 120. Quest Medical Main Business
Table 121. Quest Medical Latest Developments
Table 122. Sanofi Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 124. Sanofi Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments
Table 127. Takeda Pharmaceutical Basic Information, Inflammatory Bowel Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Product Portfolios and Specifications
Table 129. Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 130. Takeda Pharmaceutical Main Business
Table 131. Takeda Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Inflammatory Bowel Disease Drugs
Figure 2. Inflammatory Bowel Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inflammatory Bowel Disease Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Inflammatory Bowel Disease Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Inflammatory Bowel Disease Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Amino-salicylates
Figure 10. Product Picture of Antibiotics
Figure 11. Product Picture of Corticosteroids
Figure 12. Product Picture of Immunomodulators
Figure 13. Product Picture of Biologics
Figure 14. Product Picture of Others
Figure 15. Global Inflammatory Bowel Disease Drugs Sales Market Share by Type in 2022
Figure 16. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Type (2018-2023)
Figure 17. Inflammatory Bowel Disease Drugs Consumed in Ulcerative Colitis
Figure 18. Global Inflammatory Bowel Disease Drugs Market: Ulcerative Colitis (2018-2023) & (K Units)
Figure 19. Inflammatory Bowel Disease Drugs Consumed in Crohns Disease
Figure 20. Global Inflammatory Bowel Disease Drugs Market: Crohns Disease (2018-2023) & (K Units)
Figure 21. Inflammatory Bowel Disease Drugs Consumed in Indeterminate Colitis
Figure 22. Global Inflammatory Bowel Disease Drugs Market: Indeterminate Colitis (2018-2023) & (K Units)
Figure 23. Inflammatory Bowel Disease Drugs Consumed in Others
Figure 24. Global Inflammatory Bowel Disease Drugs Market: Others (2018-2023) & (K Units)
Figure 25. Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2022)
Figure 26. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Application in 2022
Figure 27. Inflammatory Bowel Disease Drugs Sales Market by Company in 2022 (K Units)
Figure 28. Global Inflammatory Bowel Disease Drugs Sales Market Share by Company in 2022
Figure 29. Inflammatory Bowel Disease Drugs Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Company in 2022
Figure 31. Global Inflammatory Bowel Disease Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Inflammatory Bowel Disease Drugs Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Inflammatory Bowel Disease Drugs Sales 2018-2023 (K Units)
Figure 34. Americas Inflammatory Bowel Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 35. APAC Inflammatory Bowel Disease Drugs Sales 2018-2023 (K Units)
Figure 36. APAC Inflammatory Bowel Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 37. Europe Inflammatory Bowel Disease Drugs Sales 2018-2023 (K Units)
Figure 38. Europe Inflammatory Bowel Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Inflammatory Bowel Disease Drugs Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue 2018-2023 ($ Millions)
Figure 41. Americas Inflammatory Bowel Disease Drugs Sales Market Share by Country in 2022
Figure 42. Americas Inflammatory Bowel Disease Drugs Revenue Market Share by Country in 2022
Figure 43. Americas Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
Figure 44. Americas Inflammatory Bowel Disease Drugs Sales Market Share by Application (2018-2023)
Figure 45. United States Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Inflammatory Bowel Disease Drugs Sales Market Share by Region in 2022
Figure 50. APAC Inflammatory Bowel Disease Drugs Revenue Market Share by Regions in 2022
Figure 51. APAC Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
Figure 52. APAC Inflammatory Bowel Disease Drugs Sales Market Share by Application (2018-2023)
Figure 53. China Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Country in 2022
Figure 61. Europe Inflammatory Bowel Disease Drugs Revenue Market Share by Country in 2022
Figure 62. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
Figure 63. Europe Inflammatory Bowel Disease Drugs Sales Market Share by Application (2018-2023)
Figure 64. Germany Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Inflammatory Bowel Disease Drugs Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Inflammatory Bowel Disease Drugs Sales Market Share by Application (2018-2023)
Figure 73. Egypt Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Inflammatory Bowel Disease Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs in 2022
Figure 79. Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
Figure 80. Industry Chain Structure of Inflammatory Bowel Disease Drugs
Figure 81. Channels of Distribution
Figure 82. Global Inflammatory Bowel Disease Drugs Sales Market Forecast by Region (2024-2029)
Figure 83. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Inflammatory Bowel Disease Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Inflammatory Bowel Disease Drugs Revenue Market Share Forecast by Application (2024-2029)
Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period.
The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
Global Lansoprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 102
The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 88
According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period.
The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
Global Esomeprazole Market Research Report 2024
Published: 04-Jan-2024 Price: US 2900 Onwards Pages: 89
The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the comp......
Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 126
Market Overview of Global Irritable Bowel Syndrome (IBS) market:
According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 109
Market Overview of Global Diarrhea Drug market:
According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
Published: 27-Dec-2023 Price: US 3350 Onwards Pages: 96
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 136
Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 113
Market Overview of Global Pentasa (Ulcerative Colitis) market:
According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
